DOW INC. DL-,01/ US2605571031 /
5/23/2024 8:21:10 PM | Chg. -0.48 | Volume | Bid8:46:16 PM | Ask8:46:16 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
52.65EUR | -0.90% | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 36.98 bill.EUR | - | - |
GlobeNewswire
2/13
Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors
GlobeNewswire
1/22
60 Degrees Pharma Plans Pivotal Babesiosis Study with Tafenoquine Following Jan 17 FDA Meeting
GlobeNewswire
11/16/2023
Dow Jones Appoints Global Agency Partners to Accelerate Marketing Transformation and Subscription Gr...
GlobeNewswire
10/11/2023
Dow Jones Risk & Compliance Completes ISAE 3000 Assurance for Ninth Consecutive Year
GlobeNewswire
9/6/2023
60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conferenc...
GlobeNewswire
11/17/2021
Gildan Included on the 2021 Dow Jones Sustainability Index for the Ninth Consecutive Year